How is the Typhoid Vi Polysaccharide Vaccine Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the typhoid vi polysaccharide vaccine market size evolved in recent years?
The market size for the typhoid vi polysaccharide vaccine has seen a swift expansion in recent years. It’s projected to rise from $5.78 billion in 2024 to $6.77 billion in 2025, exhibiting a compound annual growth rate of 17.1%. Several factors have contributed to this growth in the historical period, including the prevalence of disease, worldwide health initiatives, vaccination among travelers, government-driven immunization drives, and the effectiveness and safety of the vaccine.
What are the predictions for the typhoid vi polysaccharide vaccine market size in the coming years?
The market for the typhoid vi polysaccharide vaccine is projected to experience swift expansion in the coming years, reaching a valuation of $13.36 billion by 2029 with a compound annual growth rate (CAGR) of 18.5%. The forecasted growth can be linked to widened vaccine programs, the emphasis on global health policies, vigilant epidemiological observation, a surge in travel medicine requirement and socio-environmental factors. The prediction period also reveals prominent trends such as investments in research and development, regulatory backing, epidemiological research, and heightened public health consciousness.
Get your typhoid vi polysaccharide vaccine market report here!
What key factors are fueling the growth of the typhoid vi polysaccharide vaccine market?
The increase in typhoid cases is anticipated to fuel the expansion of the typhoid VI polysaccharide vaccine market. Typhoid, a potentially deadly infection caused by the bacteria Salmonella typhi, typically spreads via contaminated food or beverages. The typhoid Vi polysaccharide vaccine is employed to inoculate adults and children who are at least 2 years old against typhoid fever triggered by Salmonella enterica serovar Typhi, otherwise known as S. Typhi. For instance, data published by the UK Health Security Agency in August 2024 indicated a spike in laboratory-confirmed symptomatic cases of enteric fever in England, Wales, and Northern Ireland between 2021 to 2022. Specifically, there was an increase in S. Typhi cases from 108 to 313, S. Paratyphi A from 31 to 135, and S. Paratyphi B from 13 to 18. Consequently, the surge in typhoid incidents is stimulating the expansion of the typhoid Vi polysaccharide vaccine market.
How is the global typhoid vi polysaccharide vaccine market divided into key segments?
The typhoid vi polysaccharide vaccine market covered in this report is segmented –
1) By Type: Child, Adult
2) By Route Of Administration: Oral, Parenteral
3) By Application: Government Institution, Private Sector, Other Applications
Subsegments:
1) By Child: Pediatric Formulations, Age-Specific Dosages
2) By Adult: Standard Adult Formulations, High-Risk Population Formulations
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8313&type=smp
Who are the key firms paving the way for growth in the typhoid vi polysaccharide vaccine market?
Major companies operating in the typhoid vi polysaccharide vaccine market are Sanofi S.A., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Emergent Biosolutions Inc., PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Bio-Med Pvt. Ltd., LG Chem, SK Chemicals Co. Ltd., Crucell Switzerland AG, Hualan Biological Engineering Inc., Indian Immunologicals Limited
Which trends are expected to transform the typhoid vi polysaccharide vaccine market?
Forming strategic alliances is becoming a notable trend in the typhoid Vi polysaccharide vaccine marketplace. Many leading players in this sector are forging partnerships to reinforce their standing in the typhoid Vi polysaccharide vaccine landscape. For example, in July 2022, The International Vaccine Institute, an organization based in South Korea that specializes in tackling infectious diseases with significant global health impact such as cholera, typhoid, shigella, and salmonella, collaborated with Moderna, an American biopharmacology corporation. This collaboration resulted in the production of the world’s first cost-effective orally administered cholera vaccine and a revolutionary typhoid conjugate vaccine.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8313
What regions are contributing significantly to the growth of the typhoid vi polysaccharide vaccine market?
Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market share in 2024. The regions covered in the typhoid vi polysaccharide vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Pediatric Vaccine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
DTP Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
